Used in pharmaceutical research as a key intermediate for developing central nervous system (CNS) agents. Shows potential in the synthesis of compounds targeting neurological disorders due to its structural affinity to neurotransmitter receptors. Commonly employed in the development of selective agonists or antagonists for neurological and psychiatric conditions. Its piperidine-oxadiazole framework enhances blood-brain barrier penetration, making it valuable in drug design for brain-targeted therapies. Also utilized in structure-activity relationship (SAR) studies to optimize potency and selectivity in novel therapeutics.